News
SEER
1.770
-2.21%
-0.040
Weekly Report: what happened at SEER last week (0415-0419)?
Weekly Report · 3d ago
Weekly Report: what happened at SEER last week (0408-0412)?
Weekly Report · 04/15 09:07
Weekly Report: what happened at SEER last week (0401-0405)?
Weekly Report · 04/08 09:07
Weekly Report: what happened at SEER last week (0325-0329)?
Weekly Report · 04/01 09:07
Weekly Report: what happened at SEER last week (0318-0322)?
Weekly Report · 03/25 09:07
Weekly Report: what happened at SEER last week (0311-0315)?
Weekly Report · 03/18 09:07
Weekly Report: what happened at SEER last week (0304-0308)?
Weekly Report · 03/11 09:07
Seer Price Target Announced at $7.00/Share by Morgan Stanley
Dow Jones · 03/05 15:51
Morgan Stanley Reinstates Equal-Weight on Seer, Announces $7 Price Target
Benzinga · 03/05 15:41
Weekly Report: what happened at SEER last week (0226-0301)?
Weekly Report · 03/04 09:07
Seer, Inc. (NASDAQ:SEER) Just Reported, And Analysts Assigned A US$7.00 Price Target
Seer, Inc.'s stock price is up 18% following its latest yearly results. Revenues of US$17m were in line with analyst predictions, but statutory losses were 7.1% smaller than expected. The analysts have updated their estimates for Seer's revenues for the next year. The company is expected to lose US$1.35 per share in the year after. However, Seer is still expected to grow faster than its industry.
Simply Wall St · 03/02 14:43
Analysts Offer Insights on Healthcare Companies: Seer (SEER) and Biohaven Ltd. (BHVN)
TipRanks · 03/01 02:40
Earnings Scheduled For February 29, 2024
Frontline is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. Canadian Imperial Bank is projected to report earnings for its fourth quarter. Frontline is one of a number of companies to report before the bell on Thursday.
Benzinga · 02/29 10:15
Seer Q4 2023 Earnings Preview
Seeking Alpha · 02/28 22:35
Weekly Report: what happened at SEER last week (0219-0223)?
Weekly Report · 02/26 09:07
Weekly Report: what happened at SEER last week (0212-0216)?
Weekly Report · 02/19 09:08
Seer, Inc.: [Amend]Statement of acquisition of beneficial ownership by individuals
Press release · 02/14 03:23
Weekly Report: what happened at SEER last week (0205-0209)?
Weekly Report · 02/12 09:07
Zoom Video And 2 Other Stocks Insiders Are Selling
Nasdaq 100 closed higher by around 1% on Wednesday. Investors focused on some notable insider trades. Zoom Video Communications CEO Eric Yuan sold a total of 4,842 shares for $308,225. Procore Technologies, Inc. Sold 15,384 shares for an average of $71.96.
Benzinga · 02/08 12:56
Seer Proteograph Enables Unprecedented Genetic Marker Mapping For Proteogenomics Studies To Advance Drug And Biomarker Discovery
Study led by Weill Cornell Medicine demonstrates identification of protein altering variants for population-scale protein quantitative trait loci (pQTL) studies Proteograph Product Suite enables scalable deep, unbiased proteomics by mass spectrometry and overcomes limitations of affinity-based methods.
Benzinga · 02/06 13:10
More
Webull provides a variety of real-time SEER stock news. You can receive the latest news about Seer, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About SEER
Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.